Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice

Authors: Bettina Meiser, Rajneesh Kaur, April Morrow, Michelle Peate, W. K. Tim Wong, Emily McPike, Elisa Cops, Cassandra Nichols, Rachel Austin, Miriam Fine, Letitia Thrupp, Robyn Ward, Finlay Macrae, Janet E. Hiller, Alison H. Trainer, Gillian Mitchell, for the ICCon Audit Study Collaborative Group

Source: Hereditary Cancer in Clinical Practice, Vol 19, Iss 1, Pp 1-11 (2021)

Subject Terms: Guidelines, Compliance, Genetic testing, Cancer risk, BRCA1 and BRCA2, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282, Genetics, QH426-470

File Description: electronic resource

Relation: https://doaj.org/toc/1897-4287

Access URL: https://doaj.org/article/0ae049dad4464976aae50cdb8824169c

Impact of national guidelines on use of BRCA1/2 germline testing, risk management advice given to women with pathogenic BRCA1/2 variants and uptake of advice.

Authors: Meiser, Bettina, Kaur, Rajneesh, Morrow, April, Peate, Michelle, Wong, W. K. Tim, McPike, Emily, Cops, Elisa, Nichols, Cassandra, Austin, Rachel, Fine, Miriam, Thrupp, Letitia, Ward, Robyn, Macrae, Finlay, Hiller, Janet E., Trainer, Alison H., Mitchell, Gillian, for the ICCon Audit Study Collaborative Group, Susman, R., Pachter, N., Goodwin, A.

Source: Hereditary Cancer in Clinical Practice; 4/9/2021, Vol. 19 Issue 1, p1-11, 11p

Subject Terms: MAGNETIC resonance imaging, MEDICAL personnel, GENETIC testing, GERM cells, CANCER genetics

Evaluation of implementation of risk management guidelines for carriers of pathogenic variants in mismatch repair genes: a nationwide audit of familial cancer clinics.

Authors: Meiser, B., Kaur, R., Kirk, J., Morrow, A., Peate, M., Wong, W. K. T., McPike, E., Cops, E., Dowson, C., Austin, R., Fine, M., Thrupp, L., Ward, R., Macrae, F., Hiller, J. E., Trainer, A. H., Mitchell, G., for the ICCon Audit Study Collaborative Group, Susman, R., Pachter, N.

Source: Familial Cancer; Oct2020, Vol. 19 Issue 4, p337-346, 10p

Subject Terms: DNA mismatch repair, RISK management in business, RISK assessment, BEHAVIOR, INTER-observer reliability, GUIDELINES